CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,745 | -3.1% | 1,518,831 | +7.3% | 1.92% | +34.0% |
| Q2 2023 | $46,191 | -4.0% | 1,416,031 | +3.6% | 1.43% | -49.9% |
| Q1 2023 | $48,106 | +5.0% | 1,367,023 | +36.7% | 2.86% | +11.8% |
| Q4 2022 | $45,820 | -99.9% | 1,000,000 | 0.0% | 2.56% | +23.6% |
| Q3 2022 | $48,450,000 | -3.3% | 1,000,000 | -21.6% | 2.07% | -22.7% |
| Q2 2022 | $50,095,000 | +36.1% | 1,275,000 | +27.5% | 2.68% | +73.7% |
| Q1 2022 | $36,810,000 | -19.2% | 1,000,000 | 0.0% | 1.54% | +24.6% |
| Q4 2021 | $45,580,000 | -1.9% | 1,000,000 | -23.1% | 1.24% | +18.9% |
| Q3 2021 | $46,462,000 | +369.6% | 1,300,000 | +160.0% | 1.04% | +417.4% |
| Q2 2021 | $9,895,000 | -4.8% | 500,000 | 0.0% | 0.20% | -9.9% |
| Q4 2020 | $10,390,000 | – | 500,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |